Venus Concept (VERO): This nano-cap company ($100M+ revenue) appoints a new CEO who is a former top executive of Valeant Pharmaceuticals; Mixed track record
member.snowballresearch.com
Venus Concept (VERO): This nano-cap company ($100M+ revenue) appoints a new CEO who is a former top executive of Valeant Pharmaceuticals; Mixed track record
Apr 26, 2024
∙ Paid
Share this post
Venus Concept (VERO): This nano-cap company ($100M+ revenue) appoints a new CEO who is a former top executive of Valeant Pharmaceuticals; Mixed track record